ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
A bio-native AI company focused on drug discovery has joined the Russell 3000E index. The company is scheduled to report earnings on July 22. This milestone marks the firm's entry into a broad-market index tracking U.S. equities.
Tap to vote and see what everyone thinks.
Summary by ByteBrief